Healthcare Services

Hepatitis C Market Size Outlook and Demand Growth Across 2026–2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Hepatitis C Market Over The Period 2026–2030?

The hepatitis c market has seen significant expansion in recent years. Its value is expected to rise from $75.72 billion in 2025 to $86.72 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.5%. Historically, this market growth can be attributed to several factors including improved blood screening practices, expansion of antiviral drug availability, increased diagnosis rates, higher awareness of viral hepatitis, and support from public health initiatives.

The hepatitis c market is projected to experience swift expansion in the coming years. This market is anticipated to reach a valuation of $153.67 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.4%. Key drivers for this growth over the forecast period include more aggressive elimination goals set by health organizations, increased financial commitments to hepatitis screening, wider implementation of streamlined treatment approaches, the spread of telemedicine-supported care, and improved accessibility in developing regions. Significant trends anticipated during the forecast period involve the greater uptake of direct-acting antivirals, an intensified emphasis on early detection initiatives, broadened availability of curative therapies, the proliferation of public health sensitization efforts, and a heightened commitment to ensuring treatment compliance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp

Which Major Factors Are Driving The Expansion Of The Hepatitis C Market?

The hepatitis C market is anticipated to expand due to an expected rise in viral infections. These infections refer to conditions within the body caused by a virus. Hepatitis C treatment works by eradicating the viral infection and subsequently restoring the immune response in affected patients following viral clearance. For instance, in August 2024, data from the Centers for Disease Control and Prevention, a US-based public health agency, showed an increase in the percentage of individuals with Parvovirus B19, a seasonal respiratory viral infection. This percentage rose across all age groups from 3% during 2022–2024 to 10% in June 2024. The most significant surge occurred in children aged 5–9 years, where prevalence escalated from 15% over 2022–2024 to 40% by June 2024. Additionally, the proportion of pooled samples containing parvovirus B19 DNA levels significantly increased from 1.5% in December 2023 to 19.9% in June 2024. These growing instances of viral infections are therefore propelling the hepatitis C market.

How Is The Hepatitis C Market Divided Into Its Major Segments?

The hepatitis c market covered in this report is segmented –

1) By Type: Chronic Hepatitis C, Acute Hepatitis C

2) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis

3) By Distribution Channel: Hospital And Retail Pharmacies, Online Pharmacies

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Research Institutes, Home Care Settings

Subsegments:

1) By Chronic Hepatitis C: Genotype 1, Genotype 2, Genotype 3, Genotype 4, Genotype 5, Genotype 6

2) By Acute Hepatitis C: Symptomatic, Asymptomatic

What Trends Are Advancing Progress In The Hepatitis C Market?

Leading companies in the hepatitis C market are concentrating on developing sophisticated offerings, such as dual antigen and antibody diagnostic tests, to enhance the accuracy and efficiency of early detection and treatment. A dual antigen and antibody diagnostic test identifies both the presence of hepatitis C virus (HCV) antigens and antibodies in a patient’s blood. For instance, in July 2023, Roche Diagnostics, a Switzerland-based company that develops diagnostic tests, instruments, and digital solutions, launched Elecsys HCV Duo in India. Elecsys HCV Duo is a dual antigen and antibody diagnostic test engineered for the simultaneous detection of both the hepatitis C virus (HCV) antigen and antibodies from a single plasma or serum sample. The test’s dual detection capability addresses the challenge of asymptomatic early infections, which often go undiagnosed due to the absence of antibodies in the initial stages. By enabling earlier identification of active infections, the Elecsys HCV Duo helps healthcare providers initiate appropriate treatment plans more quickly, potentially diminishing disease progression and transmission rates.

Who Are The Prominent Organizations Shaping The Hepatitis C Market?

Major companies operating in the hepatitis c market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Ltd., Biocon Limited

Read the full hepatitis c market report here:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Which Region Currently Holds The Largest Share Of The Hepatitis C Market?

North America was the largest region in the hepatitis C market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hepatitis C Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12582&type=smp

Browse Through More Reports Similar to the Global Hepatitis C Market 2026, By The Business Research Company

Viral Hepatitis Global Market Report

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Preventive Vaccines Global Market Report

https://www.thebusinessresearchcompany.com/report/preventive-vaccines-global-market-report

Hepatitis Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795